BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.165
+0.050 (1.61%)
At close: Jun 26, 2026, 4:00 PM EDT
3.180
+0.015 (0.47%)
After-hours: Jun 26, 2026, 4:10 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $13.11 million as of June 26, 2026. Its market cap has decreased by -4.97% in one year.
Market Cap
13.11M
Enterprise Value
8.77M
1-Year Change
-4.97%
Ranking
Category
Stock Price
$3.17
Market Cap Chart
Since July 25, 2011, BioLineRx's market cap has decreased from $68.58M to $13.11M, a decrease of -80.89%. That is a compound annual growth rate of -10.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 13.11M | 0.02% |
| Dec 31, 2025 | 13.10M | -44.21% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 14.81M |
| Cocrystal Pharma | 13.93M |
| Passage Bio | 13.89M |
| Lexaria Bioscience | 13.56M |
| Cyclerion Therapeutics | 13.44M |
| BioVie | 13.42M |
| IN8bio | 13.39M |
| Traws Pharma | 12.61M |